Virus impact in U.K. pushes Walgreens to loss in quarter
The coronavirus pandemic pushed Walgreens to a $1.7 billion loss in the most recent quarter with customers staying home or limiting shopping to essential supplies from grocery stores.
The drugstore chain said Thursday that the rapidly spreading virus took a bite of between $700 million and $750 million from sales, with much of the damage coming from outside the United States.
Walgreens booked non-cash impairment charges of $2 billion in the quarter due to its Boots UK operating loss and continued uncertainty about how long the pandemic will go on. Without those charges, Walgreens posted quarterly earnings of 83 cents per share. Sales grew less than 1%, to $34.63 billion.
Analysts expected a substantial hit to profits, but the size of the loss exceeded those expectations. Shares of Walgreens Boots Alliance Inc. fell nearly 8%, close to a new low for the year.
More companies of all sizes will begin releasing details about their financial performances over the past three months as COVID-19 seized economies in Europe, as well as North and South America. Walgreen’s quarter ended May 31, encapsulating a threemonth period in which consumer activity came to a screeching halt.
Walgreens furloughed more than 16,000 employees at the peak of the pandemic in the United Kingdom. Sales at its Boots stores there dropped nearly 28% on a constant currency basis. April foot traffic plunged 85%.
While stores remained open to provide pharmacy services, Boots’ profitable beauty and fragrance counters were closed.
The impairment charges illustrated “a remarkable deterioration in asset value,” said Neil Saunders, managing director for GlobalData Retail, in a research note.
Walgreens Boots Alliance Inc., based in Deerfield, Illinois, runs more than 9,200 stores in the United States and has more than 18,750 locations internationally.